(a) (b) Figure S1 . PR expression did not affect by palbociclib treatment. (a,b) ARK2 (left panel) and HEC1B cells (right panel) were treated with vehicle (−) or different doses of Palbociclib (2, 4, 8µM) for 24 h. Cell lysates were subsequently resolved on SDS-PAGE and subjected to immunoblotting with antibodies raised against PR, ERα and β-actin. Densitometry-derived values (bottom) are normalized with the control that was set as 1. Data shown are derived from three independent experiments. β-actin serves as the loading control for normalization. Figure S2 . Palbociclib induces ERα expression in late-passage (n >40) Ishikawa endometrial cancer cells. Ishikawa were treated with vehicle (−) or different doses of Palbociclib (2, 4 µM) for 24 h. Cell lysates were subsequently resolved on SDS-PAGE and subjected to immunoblotting with antibodies raised against ERα and β-actin. Densitometry-derived values (bottom) are normalized with the control that was set as 1. Data shown are derived from three independent experiments. β-actin serves as the loading control for normalization.
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